Brett Kaplan

Brett Kaplan is the current CFO & Corporate Development Officer at Chroma Medicine. Brett has held this position since November of 2018. Prior to that, they were the Chief Financial Officer at Prevail Therapeutics from August of 2010 to November of 2018. Brett has also held positions at Evercore and Cowen and Company as a Managing Director and Vice President, respectively. Brett has also worked as a Director, Corporate Development at Cubist Pharmaceuticals and as a Manager, Strategic Medical Marketing at Biopure Corporation. Brett's career began at Eli Lilly where they worked as a Manager, Corporate Development and Strategy from January of 2001 to December of 2002.

Brett Kaplan has an MBA from the University of the Witwatersrand and an MBBCh from the same school. Brett also has a degree from Groote Schuur and King David.

Some of their coworkers include Vic Myers - President and CSO. Brett Kaplan reports to Catherine Stehman-Breen, CEO.